| 價(jià)格 | 詢價(jià) |
| 包裝 | 1removed |
| 最小起訂量 | 1removed |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-05-08 |
| 中文名稱(chēng):二甲苯磺酸拉帕替尼單水合物 | 英文名稱(chēng):Lapatinib ditosylate monohydrate |
| CAS:388082-78-8 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 98.00% | 產(chǎn)品類(lèi)別: 抑制劑 |
| 貨號(hào): T001|T0078L |
| 名稱(chēng) | Lapatinib ditosylate monohydrate |
| 描述 | Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury. |
| 激酶實(shí)驗(yàn) | In vitro kinase assays: The IC50 values for inhibition of enzyme activity are generated by measuring inhibition of phosphorylation of a peptide substrate. The intracellular kinase domains of EGFR and ErbB2 are purified from a baculovirus expression system. EGFR and ErbB2 reactions are performed in 96-well polystyrene round-bottomed plates in a final volume of 45 μL. Reaction mixtures contain 50 mM 4-morpholinepropanesulfonic acid (pH 7.5), 2 mM MnCl2, 10 μM ATP, 1 μCi of [γ33P] ATP/reaction, 50 μM Peptide A [Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2], 1 mM dithiothreitol, and 1 μL of DMSO containing serial dilutions of Lapatinib beginning at 10 μM. The reaction is initiated by adding the indicated purified type-1 receptor intracellular domain. The amount of enzyme added is 1 pmol/reaction (20 nM). Reactions are terminated after 10 minutes at 23°C by adding 45 μL of 0.5% phosphoric acid in water. The terminated reaction mix (75 μL) is transferred to phosphocellulose filter plates. The plates are filtered and washed three times with 200 μL of 0.5% phosphoric acid. Scintillation cocktail (50 μL) is added to each well, and the assay is quantified by counting in a Packard Topcount. IC50 values are generated from 10-point dose-response curves. |
| 存儲(chǔ)條件 | Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+90% Saline : 10 mg/mL (10.6 mM), Solution. DMSO : 250 mg/mL (264.98 mM), Sonication is recommended. |
| 關(guān)鍵字 | Tyverb | Tykerb | Lapatinib ditoluenesulfonate | HER2/ErbB2 | GW572016 ditosylate | GW2016 ditosylate | Ferroptosis | EGFR | Autophagy |
| 相關(guān)產(chǎn)品 | Guanidine hydrochloride | Naringin | Sodium Molybdate | Aceglutamide | Alginic acid | Hemin | Hydroxychloroquine | Sildenafil citrate | Stavudine | Tamoxifen | Adenosine | Paeonol |
| 相關(guān)庫(kù) | 抑制劑庫(kù) | 抗癌活性化合物庫(kù) | 抗癌上市藥物庫(kù) | 已知活性化合物庫(kù) | EMA 上市藥物庫(kù) | FDA 上市藥物庫(kù) | 免疫/炎癥分子化合物庫(kù) | 膜蛋白靶向化合物庫(kù) | FDA 上市激酶抑制劑庫(kù) | 藥物功能重定位化合物庫(kù) | 抗癌臨床化合物庫(kù) | 抗癌藥物庫(kù) |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.2651萬(wàn)人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
| 產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP6年
|
深圳菲斯生物科技有限公司
|
2026-07-31 | |
| 詢價(jià) |
VIP2年
|
湖北源夢(mèng)生物科技有限公司
|
2026-07-31 | |
| 詢價(jià) |
VIP3年
|
普善實(shí)業(yè)(陜西)有限公司
|
2026-07-31 | |
| 詢價(jià) |
VIP3年
|
淄博麗碩化工貿(mào)易有限公司
|
2026-07-31 | |
| 詢價(jià) |
VIP13年
|
深圳振強(qiáng)生物技術(shù)有限公司
|
2026-07-31 | |
| 詢價(jià) |
VIP11年
|
滄州恩科醫(yī)藥科技有限公司
|
2026-07-30 | |
| 詢價(jià) |
VIP2年
|
滄州恩科醫(yī)藥科技有限公司
|
2026-07-30 | |
| 詢價(jià) |
VIP7年
|
上海澤葉生物科技有限公司
|
2026-07-30 | |
| 詢價(jià) |
VIP1年
|
海南承和醫(yī)藥科技有限公司
|
2026-07-30 | |
| ¥549 |
VIP5年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2026-07-27 |